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Intracellular Targeting Specificity of Novel
Phthalocyanines Assessed in a Host-Parasite Model for
Developing Potential Photodynamic Medicine
Sujoy Dutta1*, Benson G. Ongarora2, Hairong Li2, Maria da Graca H. Vicente2, Bala K. Kolli1, Kwang Poo
Chang1
1 Department of Microbiology/Immunology, Chicago Medical School/Rosalind Franklin University of Medicine and Science, North Chicago, Illinois, United States of
America, 2 Department of Chemistry, Louisiana State University, Baton Rouge, Louisiana, United States of America

Abstract
Photodynamic therapy, unlikely to elicit drug-resistance, deserves attention as a strategy to counter this outstanding
problem common to the chemotherapy of all diseases. Previously, we have broadened the applicability of this modality to
photodynamic vaccination by exploiting the unusual properties of the trypanosomatid protozoa, Leishmania, i.e., their
innate ability of homing to the phagolysosomes of the antigen-presenting cells and their selective photolysis therein, using
transgenic mutants endogenously inducible for porphyrin accumulation. Here, we extended the utility of this host-parasite
model for in vitro photodynamic therapy and vaccination by exploring exogenously supplied photosensitizers. Seventeen
novel phthalocyanines (Pcs) were screened in vitro for their photolytic activity against cultured Leishmania. Pcs rendered
cationic and soluble (csPcs) for cellular uptake were phototoxic to both parasite and host cells, i.e., macrophages and
dendritic cells. The csPcs that targeted to mitochondria were more photolytic than those restricted to the endocytic
compartments. Treatment of infected cells with endocytic csPcs resulted in their accumulation in Leishmania-containing
phagolysosomes, indicative of reaching their target for photodynamic therapy, although their parasite versus host
specificity is limited to a narrow range of csPc concentrations. In contrast, Leishmania pre-loaded with csPc were selectively
photolyzed intracellularly, leaving host cells viable. Pre-illumination of such csPc-loaded Leishmania did not hinder their
infectivity, but ensured their intracellular lysis. Ovalbumin (OVA) so delivered by photo-inactivated OVA transfectants to
mouse macrophages and dendritic cells were co-presented with MHC Class I molecules by these antigen presenting cells to
activate OVA epitope-specific CD8+T cells. The in vitro evidence presented here demonstrates for the first time not only the
potential of endocytic csPcs for effective photodynamic therapy against Leishmania but also their utility in photoinactivation of Leishmania to produce a safe carrier to express and deliver a defined antigen with enhanced cell-mediated
immunity.
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developed from the continuous use of ineffective drugs, e. g.
pentavalent antimony [14]. Consequently, clinical management of
these diseases is difficult [15,16], while vaccines are still under
development [17,18]. In natural infections, all pathogenic
Leishmania spp. show the homing specificity to parasitize mononuclear phagocytes, e.g. macrophages (MC) and dendritic cells (DC)
[19–21]. MCs are the exclusive host cells where Leishmania reside
in their phagolysosomes [20]. How PS can be targeted to this site
against Leishmania with specificity is a challenging issue.
While Leishmania is a potential target of therapeutic PT, it is also
uniquely exploitable to facilitate PT against other diseases due to
its unusual mechanism of parasitism in the MC phagolysosome.
Attenuated Leishmania thus may be used as a carrier for delivery of
drugs/vaccines to this site for activation or presentation to
enhance their activities. Previously, we have obtained evidence
for this by using uroporphyrin I (URO) as a potent leishmanolytic
PS, which was induced endogenously for selective accumulation in
transgenic mutants, but not in the host cells, for effective

Introduction
Photodynamic therapy (PT) eliminates diseased cells/pathogens
by using photosensitizers (PS) that are excitable by light to produce
cytotoxic reactive oxygen species (ROS) in the presence of oxygen
[1]. Since the ROS simultaneously attack multiple molecules of
very different properties, PT is considered to have the potential to
circumvent the problem of drug-resistance common to both
infectious [2] and non-infectious diseases [3,4].
Recently, PT has been explored for treating clinical and
experimental cutaneous leishmaniasis [5–12]. The causative
agents of this vector-borne, zoonotic disease are trypanosomatid
protozoa of Leishmania spp., which is wide-spread, having an annual
incidence of ,2 million cases in ,90 countries, putting a
worldwide population of 350 million at risk [13]. Effective drugs
have never been developed specifically for this and related
diseases, i. e. the debilitating mucocutaneous leishmaniasis and
the often fatal visceral leishmaniasis. As expected, resistance has
PLoS ONE | www.plosone.org
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the csPc reached higher loading concentrations of 10–100 mM
(Figure 2 C–E, red & black squares). At these concentrations,
the 3 csPcs were 20–50 fold more photolytic to Leishmania than to
the MCs. Leishmania treated with $10 mM csPcs and light-exposed
failed to grow when inoculated into their culture medium for
incubation for up to 7 days (not shown). MCs also behaved
similarly but only when treated with 100 mM csPc 3.5. The
necessity of prolonged cell-csPc incubation for manifestation of the
phototoxic phenotypes suggests that cellular uptake of the csPcs is
a prerequisite for their effectiveness. This was shown clearly by
fluorescence microscopy of Leishmania promastigotes (Figure 3 A–
C) and axenic amastigotes (Figure 3 A9–C9) pre-loaded with the 3
representative csPcs. Cells exposed to csPc3.5 produced more
intracellular fluorescence than those to csPcs 14/15, as noted by
both fluorescence microscopy and flow cytometry (not shown).
Overall, the same csPcs are photolytically more effective against
both stages of Leishmania than their host cells under certain
conditions, while none of the Pcs examined is cytotoxic without
illumination.

photodynamic vaccination [22,23]. Photo-sensitization of Leishmania with exogenously supplied PS presents an alternative
approach to achieve the same aim. Our previous studies along
this line indicate that photolytic activity and specificity of PS is
correlated with its cellular uptake and intracellular trafficking
[7,24]. Thus, while URO generated intracellularly is highly
phototoxic, exogenously supplied URO is not taken up by cells
and is thus photolytically inactive [24]. In contrast, exogenously
supplied aluminum phthalocyanine chloride (AlPhCl) becomes
associated with Leishmania rapidly and sensitized them for
photolysis, but this is non-selective when sensitized parasites were
used to infect the host cells, as the latter were also lysed [7]. These
preliminary observations underscore the necessity of further
investigation with additional PS to understand their structurefunction relationships.
In the present study, 17 novel phthalocyanines (Pc) were
examined for PT activities in our host-parasite in vitro model.
Soluble cationic Pcs (csPcs), which were taken up by endocytosis or
targeted to mitochondria, were found to mediate photolysis
effectively. While both are photolytic to Leishmania, they differ in
parasite versus host selectivity. From a series of in vitro studies, we
obtained evidence, indicating that the endocytic csPcs are
favorably disposed for PT against cutaneous leishmaniasis; and
that csPc-loaded Leishmania photolytically delivers a model antigen
to MCs and DCs for presentation to activate specific T cells,
supportive of their carrier potential for immuno-prophylactic and
–therapeutic PT.

Photolytic activities of the effective csPcs vary with their
specificity of targeting to different cell organelles in both
Leishmania and macrophages
Fluorescence microscopy of csPc-exposed Leishmania and MCs
showed that anilinium csPc 3.5 and pyridyloxy csPcs 14/15 colocalized with mitochondrial and endocytic markers, respectively
(Figure 4). By the same approach, we observed that csPcs 11–13
and csPcs 3.6/3.7 were also endocytic, while csPcs 3.2/3.4
mitochondrial; and that Pc 10 was cytosolic in MCs, but
undetectable in Leishmania (not shown). DIC imaging of Leishmania
(Figure 4 [A–C]) and 49, 6-diamidino-2-phenylindole (DAPI)staining of MC’s nuclei (Figure 4 [D–F]) showed their cellular
integrity and provided reference for orientation of their cell
organelles. csPcs 14/15 co-localized with the endocytic marker, i.
e. Fluorescein isothiocyanate labeled dextran (FITC-dextran), in
both Leishmania and MCs (Figure 4 [A–B] and [D–E] merged
panels). Leishmania endocytic vesicles are known to aggregate into
a single multi-vesicular body, which was rendered visible
apparently by the accumulation of FITC-dextran and/or csPcs
to a sufficient level in this site (Figure 4 [A–B] and [D–E] 2nd
and 3rd panels). In Leishmania, both csPc fluorescence (Figure 4
A, 2nd panels, white arrow) and FITC-dextran fluorescence
(Figure 4 A 3rd panels, white arrow) were also detected in the
flagellar reservoirs where extracellular molecules are taken up via
endocytically active lining membrane. In MCs, csPc 14/15
fluorescence (Figure 4 [D–E] 2nd panels) and FITC-dextran
fluorescence (Figure 4 [D–E] 3rd panels) were seen in vesicles
scattered in the cytoplasm. Many csPc-positive vesicles overlapped
with those containing FITC dextran (Figure 4 [D–E] 2nd, 3rd &
merged panels, white arrows), indicating that csPc15 was
also taken up by MCs endocytically. CsPc 3.5 fluorescence was
seen to overlap with the rhodamine 123 mitochondrial marker of
Leishmania (Figure 4 C) and with the staining pattern of
mitotracker green in MCs (Figure 4 F). The cellular targeting
specificity of these different csPcs is underscored by a lack of colocalization of Pc15 with mitotracker, and of Pc 3.5 with dextranFITC in both Leishmania (Figure S1, A–B) and MCs (Figure S1,
C–D).
Notably, the cellular targeting of these csPcs is correlated with
their photolytic potency: the mitochondrial csPc 3.5 is more
photolytic to Leishmania (Cf Figure 2 A and B) and produced much
more ROS in light-exposed lysates (data not shown) than the
endocytic csPcs 14/15.

Results
csPcs sensitize Leishmania and macrophages
differentially for photolysis
All Pcs (Figure 1) were assessed initially at 3 different
concentrations each (0.1–10 mM) against the promastigote stage
(Figure 2A). Cell suspensions were first treated with Pcs in the dark
overnight and then exposed to light at a fluence of 2.0 J/cm2
(referred to as light exposure hereafter). Of the 17 Pcs examined
under these conditions, 9 produced phototoxic phenotypes, as seen
microscopically as loss of cell motility and/or integrity. These
phenotypes were not noticeable immediately but were observed after
incubation for ,16 hrs when cell viability was assessed by (3-(4,5Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assays. Phototoxicity so determined was dose-dependent, but varied
with the 9 effective Pcs. Pc 3.5 was most photolytic (Figure 2A), as
indicated by the manifestation of cytolysis more rapidly than others
after illumination (not shown). These 9 anti-promastigote Pcs were
also found equally photolytic against the axenic amastigotes
(Figure 2B vs Figure 2A). Notably, the effective Pcs are all
cationic and soluble (csPc), i. e. 4 anilinium Pcs 3.4 to 3.7 and 5
pyridyloxy Pcs 11 to15 (see Figure 1).
Three most effective csPcs of the 2 chemical series, i. e. Pcs 3.5,
and 14/15, were further studied. Both Leishmania stages and their
MC host cells were exposed separately to these csPcs in serial
dilutions (0.001 to 100 mM) and washed to remove non-cell
associated Pcs (referred to as ‘‘pre-loading’’ hereafter) before lightexposure. At 16 hrs post-illumination, promastigotes treated with
Pc 3.5 became more granular, whereas those with csPcs 14/15 lost
motility, but remained morphologically intact (not shown). By
MTT assays, both parasites and MCs were found, as expected,
sensitive to the photolytic activities of the 3 csPcs, but the kinetics
of their susceptibility varied greatly with the Pc concentration
(Figure 2 C–E). Viability of the MCs decreased with increasing
csPc concentrations (Figure 2 C–E green triangle), whereas
that of both Leishmania stages remained unchanged initially until
PLoS ONE | www.plosone.org
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Figure 1. Structures of zinc-phthalocyanines (Zn-Pc) and silicon-phthalocyanines (Si-Pc) used in this study. Pc 1–3.7, anilinium
phthalocyanines; Pc 10–15, pyridyloxy phthalocyanines.
doi:10.1371/journal.pone.0020786.g001

but not with csPc 3.5 (not shown). This difference was shown
quantitatively by MTT assays of the surviving parasites, which
were recovered from treated cultures for growth as promastigotes
in vitro (Figure 5 [C] Lower panel). Infected cultures treated
with both csPcs at higher concentrations of 10–100 mM yielded
few viable MCs and no viable Leishmania. At the lower
concentration range of 0.001 to 1 mM, the viable Leishmania
recovered per culture of infected MCs was 3–4 fold less when
treated with csPc 15 than with csPc 3.5 (Figure 5 [C] square vs
triangle). Significantly, the photolytic suppression of viable
parasites to this lower level was accompanied by no loss of host
cell viability at 0.01 mM of csPc 15 (Figure 5 [C] Arrows).
The intracellular targeting of endocytic csPc 15 and mitochondrial csPc 3.5 correlates well with their differential activities seen
against the phagolysosomal Leishmania in infected cells. Nevertheless, the margin of parasite versus host selectivity for the
photolytically effective concentrations of csPc 15 is small. This
limitation is not unexpected, considering the presence of endocytic
csPc 15 not only in the phagolysosomes but also in some
endosomes, which may be less ROS-resistant.

Phagolysosomal Leishmania were differentially sensitized
for photolysis by treating infected macrophages with
endocytic csPc, but not with mitochondrial csPc
L. amazonensis infection is known to distend the phagolysosomes
of MCs into large parasitophorous vacuoles (PV) (Figure 5 [A]–
[B] Phase contrast, PV), rendering the parasites therein easily
visible, especially when using Leishmania transfectants expressing
green fluorescent protein (GFP) (Fluorescence-EGFP). Exposure of the infected MCs to the endocytic csPc15 led to its
accumulation in these PV (Figure 5 [A] Fluorescence Pc) and
thus co-localization with the GFP-Leishmania (Figure 5 [A]
Merged). Co-existence of the csPc and the intra-PV Leishmania
is suggested by the mergence of GFP-csPc fluorescence (yellow) in
most of them. In contrast, exposure of similarly infected MCs to
the mitochondrial csPc 3.5 resulted in its cytoplasmic or
mitochondrial fluorescence (Figure 5 [B] Fluorescence Pc),
but no co-localization with GFP Leishmania in the PV (Figure 5
[B] Fluorescence GFP and Merged).
The anti-Leishmania PT potential of endocytic csPcs was shown
by illumination of the infected MCs after treatment with csPc15 in
comparison to csPc 3.5 (Figure 5 C). By MTT assays, the viability
of the host cells was found to decrease dose-dependently following
similar kinetics in the presence of both csPcs (Figure 5 [C]
Upper panel). Fluorescence microscopy of these cells for the
intra-PV GFP-Leishmania initially revealed that the intensity of
their GFP fluorescence diminished after treatment with csPc15,
PLoS ONE | www.plosone.org

CsPc pre-loaded Leishmania were as infective to host
cells as the untreated Leishmania and were selectively
photolysed substantially, leaving host cells unaffected
The parasite versus host specificity for photolysis was
enhanced significantly when Leishmania pre-loaded with csPcs
3
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Figure 2. Photosensitivity of L. amazonensis and macrophages to different phthalocyanines. [A] Promastigotes and [B] axenic
amastigotes were treated with and light-exposed in the presence of csPcs (0.1–10 mM) as indicated. [C]Pc14, [D]Pc15, and [E]Pc3.5:
Promastigotes, axenic amastigotes and J774 macrophages were ‘‘pre-loaded’’ with the 3 csPcs as indicated and light-exposed as described. Cell
viability was assessed 1-day later by MTT assays ([A–E]). * Not done.
doi:10.1371/journal.pone.0020786.g002

untreated, csPcs 14, 15 & 3.5) and DCs (Figure S2 A–B,
Before light exposure: Phase and Fluorescence of
untreated & csPc 3.5). At higher magnification (Figure 6
[II]A), the PVs of infected MCs were clearly seen to contain
Leishmania fluorescent in green due to GFP, in red due to csPc
and yellow for the presence of both. (Note: Population
heterogeneity of both GFP- and csPc-Leishmania in fluorescence
intensity is expected, precluding the visualization of combined
fluorescence in all individual cells). Light exposure of the

were used to infect host cells. For this study, MCs and DCs were
infected with GFP-transfectants to simplify the evaluation of
infection by fluorescence. Pre-loading of these transfectants with
csPcs 3.5, 14 and 15 (10 mM) in the dark was found to produce
no deleterious effects, leaving them fully motile and viable.
These csPc-loaded Leishmania were as infective as untreated
GFP-transfectants, producing similar intensities of intracellular
GFP fluorescence 2 days after infection of MCs (Figure 6 [I]
A–D, Before light exposure: Phase and Fluorescence of
PLoS ONE | www.plosone.org
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Figure 3. Uptake of csPcs by two different Leishmania stages. [A–C] Promastigotes and [A9–C9] axenic amastigotes were pre-loaded with
10 mM csPcs 14, 15 or 3.5, respectively. DIC, Differential interference. Fluorescence, Pc intracellular fluorescence. Scale bar = 10 mm.
doi:10.1371/journal.pone.0020786.g003

100% when assessed 1 day after illumination, but was reduced
thereafter with additional days of incubation in the dark before
illumination (Figure 6 [III] A–C, 1–3).
The results obtained indicate that Leishmania pre-loaded with
csPcs retained their innate ability of homing to phagolysosomes of
MCs and DCs. The PS is thus delivered specifically by Leishmania
to this ROS-resistant site, accounting for the specificity and
efficiency of leishmanolysis.

infected cells harboring csPc-loaded Leishmania, but not untreated Leishmania, substantially cleared the infection, as indicated by
the disappearance of the cellular GFP fluorescence from both
MCs (Figure 6[I] A9–D9 After light exposure: Phase
contrast and fluorescence of untreated versus csPcs
14, 15 & 3.5) and DCs (Figure S2 A9–B9, After light
exposure: Phase and fluorescence of untreated versus
csPcs 3.5). Persistence of GFP fluorescence in csPc-untreated,
but light-exposed controls indicates that it is not sensitive to
photo-bleaching under the conditions of illumination used. The
loss of GFP fluorescence is thus accounted for by the
degradation of GFP, as the GFP-Leishmania were photolysed
progressively in the PV, which became smaller and devoid of
visible Leishmania (Figure 6 [II] B). Significantly, the host cells
remained undisturbed, as indicated by their persistence as
monolayers of confluent adherent cells (Figure 6 [I] A–D
versus A9–D9; Figure S2 A–B versus A9–B9, Phase
contrast) and by their comparable MTT reducing activities
(not shown) before and after light exposure.
The observation was further verified under optimal conditions by infecting host cells with GFP-Leishmania, which were
pre-loaded with decreasing concentrations of csPcs. The
selectivity and efficacy of the photolytic clearance of csPcloaded Leishmania from these infected cells was clearly shown
quantitatively by flow cytometry for GFP fluorescence (Figure 6
[III]). In all cases, the % of cells with GFP-fluorescence or
Leishmania infection decreased after light exposure proportionally with increasing csPc loading concentrations; the most
striking decrease being from 1 to 10 mM (Figure 6 [III] and
figure S2 [II]). At the highest csPc loading concentration of
10 mM, photolytic clearance of the infection reached almost
PLoS ONE | www.plosone.org

Uptake of csPc pre-sensitized and pre-illuminated
Leishmania, and their intracellular photo-clearance from
macrophages
CsPc-loaded promastigotes were noted to remain structurally
intact long after light exposure. Although these doubly treated
GFP-Leishmania were unable to grow and perished eventually (see
preceding section), they were found to infect host cells as well as
those treated with csPc alone or light alone (not shown).
Endocytosis of all these GFP-Leishmania by MCs was verified by
immuno-staining their endosomes for Early Endosome Antigen 1
protein (EEA1). This marker labeled the endosomes of uninfected
cells as red fluorescent cytoplasmic vesicles (Figure 7[I]A) and colocalized with fluorescent GFP-Leishmania in the phagosomes of the
MCs, regardless of whether Leishmania were csPc-preloaded, preilluminated, treated with both or untreated (Figure 7 [I] B–D
J+[Leishmania+0+L, +Pc2L, and +Pc+L]). After incubation
for 2 days, the MCs remained infected by the control parasites
(Figure 7 [II] A and [III] A), but were cleared of the doubly
treated Leishmania, irrespective of their pre-loading with csPcs 3.5,
14 or 15 before pre-illumination (Figure 7 [II] B–D).
Quantitative flow cytometry of these cells further revealed that
5
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Figure 4. Localization of csPcs to cell organelles in Leishmania and macrophages. [A–C] Leishmania and [D–F] J774 MCs preloaded with
10 mM csPcs for 16 hrs. A–F-2nd column, csPc-positive fluorescence; A–B and D–E-3rd column, endocytic vesicles labeled with FITC-dextran; C-3rd
column, Leishmania mitochondria with rhodamine 123; F-3rd column, MC mitochondria with mitotracker green. MC nuclei DAPI-stained blue in D–F.
A–B and D–E ‘‘merged’’ shows csPc 14 and 15 colocalization with endocytic vesicles. C and F ‘‘merged’’ show csPc 3.5 & mitochondria co-localization.
Scale bar = 10 mm.
doi:10.1371/journal.pone.0020786.g004

the GFP-positive populations were significantly reduced by ,20,
,35 and ,80 fold for csPcs 14, 15 and 3.5, respectively (Figure 7
[III] B–D). The clearance of the infection from these cultures
appeared to be complete, since csPc-loaded/pre-illuminated
Leishmania failed to grow. Infection of DCs with csPc-pre-loaded
PLoS ONE | www.plosone.org

and pre-illuminated Leishmania produced a similar outcome (not
shown).
The results obtained indicate that immediately after csPcloading/illumination Leishmania remain infective, but are substantially cleared rapidly and selectively.
6
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Figure 5. Exposure of infected macrophages to endocytic and mitochondrial csPcs differentially sensitize phagolysosomal GFPLeishmania for photolysis. [A–B] csPcs localization by fluorescence microscopy. PV (Phase contrast), Large Leishmania-containing
phagolysosomes after infection of MCs with GFP-transfectants. Exposure of these cells to csPcs 15 and 3.5 (10 mM) resulted in their fluorescence at
different sites: [A](Pc), csPc 15 in the PV; [A](EGFP), GFP-fluorescent Leishmania in PV; [A]Merged, Co-localization of the two in the same PV;
[B](Pc), csPc 3.5 in the cytoplasm outside of PV; [B](EGFP), GFP-Leishmania in PV; [B] Merged, No co-localization of the two. Scale bar: 100 mm. [C]
Viability of infected macrophages and their intracellular Leishmania. Adherent Leishmania-infected MCs as described above were exposed to
increasing concentration of Pc 3.5 and Pc 15, washed and light-exposed. Upper panel, MTT assays for MC viability after 16 hrs at 35uC. Lower
panel, MTT assays for viability of intracellular Leishmania released from PT-treated MCs and cultured for 7 days. % & D, Samples exposed to Pc 15
and Pc 3.5, respectively. Arrows, csPc 15 versus csPc 3.5 at 0.01 mM for photolysis of intracellular Leishmania without affecting host cell viability.
*, p,0.05.
doi:10.1371/journal.pone.0020786.g005

endogenously expressed, T cell model antigen of 27 kDa
(aa 140–386) (OVA) (Figure 8[A], OVA). The transfectants,
which were csPc 15 pre-loaded and pre-illuminated, remained
infective to DCs (not shown) under the experimental conditions
used for the similarly pre-treated wild-type or GFP-Leishmania
(Figure 7). OVA delivered in this way to DC was apparently

Photolytic delivery of ovalbumin by Leishmania to DCs
presents an MHC Class I-restricted ovalbumin peptide
that activates its specific CD8+ T cell line in vitro
Leishmania transfected with the cDNA encoding a truncated
OVA was used to serve as a carrier for this xenogenic, albeit
PLoS ONE | www.plosone.org
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Figure 6. Infection of macrophages with Pc-preloaded Leishmania and selective photolysis of the latter after illumination. [I]
Fluorescence microscopy of infected cells showing light-mediated clearance of GFP Leishmania. MCs infected with GFP-Leishmania [A]
and those csPc-preloaded [B–D] were light-exposed. Phase contrast and fluorescence microscopy of cells for GFP before [A–D] and 1 day after light
exposure [A9–D9]. Note: The integrity of macrophage monolayers and the Leishmania green fluorescence clearance, except in the control
(untreated). Scale bar: 100 mm. [II] Fluorescence microscopy of csPc-/GFP-positive Leishmania in PV and their clearance by light
exposure. Scale bar: 100 mm. Upper panel: PV containing Leishmania, which fluoresce green (GFP), red (csPc) and yellow (merged) before lightexposure. Lower panel: An empty PV cleared of all fluorescent Leishmania after light-exposure. [III] Flow cytometry of GFP-Leishmania-infected
MCs for GFP fluorescence showing csPc concentration-dependent photo-clearance of the infection: The same culture sets as [I] infected
with GFP-Leishmania, but loaded with increasing concentrations of the 3 csPcs indicated. Cells were collected daily for light-exposure in 3 consecutive
days (1–3). [A–C] Flow-cytometry of cells from days 1, 2 and 3 for GFP fluorescence intensity as a measure for the infection.
doi:10.1371/journal.pone.0020786.g006

processed correctly by these antigen-presenting cells (APC) to
present the known MHC Class I-specific SIINFEKL epitope. This
is indicated by the positive reaction of this MHC-epitope complex
with a monoclonal antibody 25-D1.16, which is known to have
this specificity [25] (Figure 8[B]). The positive immuno-reaction
products, in green or pale blue when overlapped over
PLoS ONE | www.plosone.org

DAPI-stained nuclei, were present in DCs infected with these
photo-inactivated transfectants (Figure 8[B] +[Leishova+Pc+L]) at levels as in those exposed to all the SIINFEKLpositive controls (+SIINFEKL peptides, +OVA, +Leish-ova
lysates), but not in the negative controls (Medium alone,
+[Leish-wt+Pc+L]). In addition, in 3 independent experiments
8
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Figure 7. Infection of J774 macrophages with csPc-preloaded/pre-illuminated GFP-Leishmania, and their photolytic clearance. [I]
Endocytosis of Pc-preloaded/pre-illuminated GFP-Leishmania by J774 macrophages. [A] MCs light-exposed (J[+0+L]); [B] As [A], but preinfected with GFP-Leishmania (J+[Leishmania+0+L]); [C] As [B], but infected with Pc 14-preloaded Leishmania without light-exposure;
([Leishmania+Pc2L]); and [D] As [C], but infected with Pc-preloaded/pre-illuminated GFP-Leishmania (J+[Leishmania+Pc+L]). Immunofluorescence
microscopy of all cells 16 hr post-infection for EEA-1 endosome marker. Green, GFP-Leishmania; Blue, DAPI-stained MC nuclei; Red, EEA1-positive
endosomes. Note: co-localization of Leishmania GFP with endosome marker. Scale bar: 100 mm. [II] Photolytic clearance of Pc-preloaded/preilluminated GFP-Leishmania from infected cells. MCs were infected with GFP-Leishmania ([A]), and those preloaded with the 3 csPcs as
indicated ([B–D]) and light-exposed. Phase contrast and fluorescence microscopy of infection after 2 days. Note: Clearance of GFP from all doubly
treated cultures without affecting the appearance of host cell monolayers. Scale bar: 300 mm. [III] Flow-cytometric quantitation of GFP
fluorescence of the same samples used for [II], showing a ,40% infection rate in the control ([A] GFP) reduced to negligible levels in the doubly
treated groups ([B–D] GFP).
doi:10.1371/journal.pone.0020786.g007

(Figure 8[C]), both DCs and bone marrow-derived MCs (BDMC)
infected with the photo-inactivated transfectants [Leishova+Pc+L] were found to activate CD8+ Ova specific T cells
(B3Z T cells), which are known to react specifically with the MHC
PLoS ONE | www.plosone.org

Class I/SIINFEKL epitope complex, resulting in the expression of
Lac Z as the readouts [26] (Figure 8[C]). Based on this assay
under the experimental conditions used, B3Z T cells were
activated by co-cultivation with DC/BDMC+[Leish-ova+Pc+L]
9
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Figure 8. Leishmania expression of ovalbumin and its photolytic delivery to APCs for antigen presentation in vitro. [A] OVA
expression by Leishmania transfectants. Western blot of wild type and transfectants (ova) showing the presence of the Leishmania P36 in both,
but only OVA in the latter. [B] Immunodetection of the OVA-SIINFEKL/MHC Class I complex co-presentation in infected DC. OVAexpressing and WT Leishmania preloaded with 10 mM csPc 14 and light-exposed for 45 mins were prepared. DCs were exposed at 35uC for 16 hrs to
the following conditions: Negative controls, Medium alone and Pc-/light-exposed WT Leishmania (+Leishmania-wt+Pc+L); Positive controls,
100 pM SIINFEKL peptides (+SIINFEKL) and 5 mg/ml chemically pure native ovalbumin (+OVA); and experimental group, Pc- and light-exposed
ova-transfectants (+[Leishmania-ova+Pc+L]) and their lysates without light exposure (+[Leishmania-ova (lysate)). DC to Leishmania ratio
used = 1:100. Treated cells were reacted with the monoclonal specific for SIINFEKL/MHC class I molecule complex for immunofluorescence
microscopy. Note: Fine green granular products = positive reactions; Blue, DAPI-stained DC nuclei. Scale bar: 50 mm. [C] Activation of OVAspecific CD8+ T cells by BDMCs and DCs with OVA-expressing Leishmania: Positive and negative controls are described in legends below the
graph. Infected DCs and BDMCs were co-cultured with the OVA MHC class I epitope (SIINFEKL)-specific CD8+ T cell hybridoma (B3Z). LacZ reporter
gene activity measured for OVA epitope-specific B3Z T cell activation, as described. p values,0.05, as calculated by student’s t-test. Data are
presented from 2 independent experiments using BDMC and 1 representative experiment using DC as the APCs. #, not done.
doi:10.1371/journal.pone.0020786.g008

or +Leish-ova lysates to a significant level that was ,40% of those
with DC+ SIINFEKL peptides or +OVA, and virtually identical
to those of BDMC+ SIINFEKL. csPc-loaded Leishmania without
illumination [Leish-ova+Pc2L] remained infective and viable in
PLoS ONE | www.plosone.org

BDMC; activation of B3Z T cells by these infected BDMC was of
the background level, e. g. Leish-WT+Pc6L. All other negative
controls produced little or no activation (Figure 8[C] see legends
at the bottom of the bar graph).
10
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The results thus indicate that foreign antigens can be expressed
by Leishmania for csPc-mediated photolytic delivery to APC for
presentation to activate epitope-specific T-cells in vitro.

other PS reported against clinical cutaneous leishmaniasis [6,8].
The use of endocytic csPcs is expected to significantly enhance
both pharmacological effectiveness of PT as well as the posttherapeutic immune clearance of Leishmania infection. For such
applications, csPcs may be further modified for lysosomal
activation [31] to increase the margin of parasite versus host
selectivity.
Our in vitro data presented support our proposal that the PSloaded Leishmania are potentially useful carriers to deliver drugs/
vaccines to the appropriate site for pharmacological/immunological activation [23]. Leishmania pre-loaded with csPcs provide an
additional carrier inducible for destruction (Figure 6) as alternatives to the uroporphyrinogenic mutants [23]. The csPcs appear
‘‘locked up’’ in the cell organelles more tightly than membraneassociated AlPhCl [7], thereby avoiding ‘‘leaching out’’ to sensitize
host cells for photolysis, as found with the latter. Pre-illumination
of these csPc-loaded Leishmania eliminates their ability to grow,
thereby increasing the safety margin of their future applications
(Figure 7). Also, the clearance of Leishmania from infected cells
requires no additional illumination, thereby simplifying the
experimental steps. While persistence of a few Leishmania below
detection can never be ruled out, they are expected to succumb to
post-PT immune clearance under in vivo conditions, as noted
previously [22].
Evidence is further provided for the first time that specific
antigen can be expressed by Leishmania for photolytic delivery after
PS-loading to DC or BDMC to elicit a T cell response, supporting
our proposal for their utility as a vaccine carrier in immunoprophylaxis and –therapy. Transfection of Leishmania to express
OVA makes it possible to photolytically deliver it as a surrogate
vaccine for in vitro evaluation of T cell specific immune response
(Figure 8). Significantly, csPc-loaded transfectants are able to
deliver OVA to DCs and MCs for appropriate processing. Preillumination of csPc 14/15-loaded transfectants gave the most
consistent results, suggesting that the photolytic environment of
the PT preserve not only the carrier capacity of the transfectants
but also the antigenicty of OVA epitopes in these cells. Delivery of
OVA by photo-inactivated Leishmania to BDMC for this activity is
especially impressive, as it is higher even than that produced by the
lysates of these Leishmania that were supplied to APC in equivalent
amounts (Figure 8C). While DCs and MCs are susceptible to the
infection by the csPc-loaded transfectants and illumination of these
infected cells cleared the infection (Figure 6), delivery of OVA in
this way for antigen presentation produced less consistent results
(not shown). Work is still on-going to optimize the experimental
conditions. OVA SIINFEKL-MHC Class I co-presented by the
infected DCs and BDMCs is functionally active, since such APCs
are capable of activating SIINFEKL-specific CD8+ T cells. Work
is underway to evaluate the lysosomal delivery of OVA for
presentation of different OVA epitopes to specific CD4+ T cells.
Completion of the work with this and other defined antigens is
expected to provide the necessary foundation for future evaluation
of vaccine candidates photolytically delivered by Leishmania against
other diseases.

Discussion
This is the first report showing that both stages of Leishmania are
intrinsically susceptible to the photolytic activities of soluble and
cationic Zn2/Si-Pcs (csPcs) examined (Figure 1 and 2 [A–B]).
Since the axenic amastigotes are closer to the disease-causing stage
of Leishmania, their intrinsic and irrevocable susceptibility to csPcmediated cell death is especially relevant in considering csPcs as
agents for therapeutic PT against cutaneous leishmaniasis.
Photolytic activity of the csPcs requires their uptake by cells
(Figure 3), consistent with the outcome of our observations with
endogenously generated URO [24]. Additions of anilinium or
pyridyloxy groups, axial ligands and/or PEGylation to the core
structure of the Pc (Figure 1) apparently facilitate the cellular
uptake of these csPcs. These modifications increase their
cationicity for enhancing interaction with the negatively charged
cell surface, and their solubility for increased bioavailability [27]
and decreased self-quenching [28]. Subcellular localization of the
representative csPcs (Figure 4) suggests that the mechanisms of
their cellular uptake follow at least 2 different pathways, common
to both Leishmania and macrophages: endocytosis for pyridyloxy
csPcs, e. g. 14/15, and plasma and mitochondrial membrane
transport of di-anilinium csPcs, i. e. Pc 3.5. It is not known
whether the mitochondrial import of this csPc utilizes a specific
transporter, as reported for a different Pc series, e. g. Si-Pc4 [29].
Further study of the structure-function relationships of these and
other csPcs are needed to elucidate the precise mechanisms of
their cellular uptake and trafficking.
Our results together with those from previous work show that
the subcellular targeting differences of the PS figure significantly in
the photolytic phenotype observed. The subcellular targeting
specificity of the effective csPcs presented here differs from that,
which we reported previously, for endogenously induced URO
[24] and exogenously applied AlPhCl [7]. The csPcs accumulate
gradually in Leishmania, akin in timeframe to the neogenesis of
URO in porphyric mutants [23,30], but in different sites, resulting
in the manifestation of very different phototoxic phenotypes.
Flagellar motility was rapidly paralyzed by light exposure of the
uroporphyric mutants when URO began to emerge in their
cytosol [24,30], but not when Leishmania was pre-loaded with csPcs
in their endosome/phagolysosomes or mitochondria. These PSsensitized Leishmania do not lose their viability immediately after
illumination in sharp contrast to the outcome of those treated with
membrane-associated AlPhCl [7]. The cellular targeting specificity
of these and other csPcs warrants further study to understand their
mechanisms in relation to their observed differences in photodynamic properties.
In the present study, evidence is also presented for the first time
that the endocytic PS, like csPcs 14/15, are potentially useful for
therapeutic PT against phagolysosomal pathogens, e. g. Leishmania
spp. The specificity of these PS for targeting phagolysosomal
Leishmania accounts more for their effectiveness than their intrinsic
photolytic activities, as the mitochondrial csPcs are more
photolytic to promastigotes, but less leishmanolytic against those
in infected cells than the endocytic csPcs 14/15 (Figure 5A–B).
The endocytic csPcs are expected to be effective for PT in vivo by
just clearing the infection of some infected MCs so that they, once
free from Leishmania-mediated immunosuppression, are able to
initiate effective immunity to clear the remaining infection. This
scenario is consistent with some measure of success of PT using
PLoS ONE | www.plosone.org

Materials and Methods
Phthalocyanines
Synthesis of pyridyloxy Pcs and their photophysical and
photochemical properties have been reported [32]. The synthesis
of anilinium Pcs used here will be published by Maria da Graca H.
Vicente in details separately elsewhere. Figure 1 shows the
structures of anilinium Pcs (Pc 1–3.7) and pyridyloxy Pcs (Pc 10–
15) examined in the present study. All Pcs were dissolved in
11
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dimethyl sulfoxide (DMSO) (Sigma) to 100 mM. The stock
solutions were used immediately or stored in the dark at 220uC.
Cells: Used in this study were wild-type clone 12-1 of
Leishmania amazonensis (RAT/BA/74/LV78) and its GFP transfectants [7], mouse macrophage cell line J774A1 (MC) [7], mouse
bone marrow derived macrophages (BDMC), mouse dendritic
cells of the DC2.4 line (DC) [33] and the B3Z T cell hybridoma
[26]. Leishmania promastigotes, axenic amastigotes and J774A1
macrophages were grown as described [7]. BDMCs were
differentiated from bone marrow cells of 129/C57BL6 mice and
maintained in DMEM containing macrophage colony stimulating
factor [34]. DC2.4 and B3Z T cell lines were grown in
supplemented RPMI 1640 [26,33]. Leishmania transfectants were
grown for 1-cycle in drug-free medium and washed by
centrifugation up to 3-times before use.

no. 650021; Smith-Victor Co., Bartlett, IL) under a constant
temperature of ,25uC. The light source was a light box, consisting
of 2 white fluorescent tubes (15 watts each, General Electric; part
no. F15T8CW) and a light diffuser on top. A L1-250A light meter
(LI-COR) was used to read the irradiance, producing a value of
0.55 mW/cm2 that gave a fluence of 2.0 J/cm2 after exposure for
the duration of 1 hr [7].

Cell viability assays
Cells were assessed for their viability by microscopy, MTT
reducing activities [24] and growth of the survivors [7]. For
intracellular amastigotes, infected MCs were stripped from tissue
culture plates by repeated flushing of individual wells with a
Pasteur pipette. The cells suspensions were then vortexed
vigorously to break infected macrophages for releasing intracellular amastigotes. Lysates in equal aliquots from different preparations were each incubated under promastigote culture conditions.
After ,7 days of growth, parasites were assessed for viability based
on their MTT reducing activities.

OVA transfection/expression
Promastigotes were transfected by electroporation [23] with
pX63hyg-ova, consisting of a truncated ovalbumin (OVA, aa 140–
386) [35] cloned into the Bgl II expression site of pX63hyg [24].
Stable transfectants were selected and grown at 500 mg/ml of
hygromycin [24]. OVA expression in the transfectants was
assessed by Western blotting using anti-OVA rabbit antisera
(Millipore, dilution: 1: 1000) and donkey anti-rabbit IgG labeled
with fluorophore CW800 (Licor, dilution: 1: 20000). Blots were
scanned for reaction products in an Odyssey infrared scanner
(Licor). Leishmania constitutively expressed protein of 36 kDa (p36)
were included as the loading control [36].

Fluorescence/immunofluorescence microscopy
Nikon Eclipse 80i and TE2000-S microscopes equipped with
CCD cameras and Metamorphosis (version 6.1) software were
used [24]. At least 50 individual cells were examined for each
experimental and control set using specific filter sets (listed at the
end).
[1] Phthalocyanine subcellular localization: Cells ‘‘preloaded’’ with 10 mM csPcs for 16 hrs were examined. [2] Colocalization of csPcs and cellular organelle markers: The
following fluorescent markers were used: rhodamine 123 (0.2 mM)
for Leishmania mitochondria, dextran-FITC (molecular weight of
10,000) (500 mg/ml) for Leishmania endosomes [24], mitotracker
green FM (Invitrogen) for MC mitochondria and dextran-FITC
(molecular weight of 40,000, Invitrogen) for MC endosomes. [3]
Treatment of GFP-Leishmania-infected macrophages
with different csPcs. MCs were infected with GFP-Leishmania
for 3 days in 24 well plates, washed and exposed to 10 mM Pcs in
the dark for 16 hrs and then examined by using the FITC filter set.
[4] Uptake of csPc-loaded/light-exposed GFP-Leishmania into EEA1-positive endosomes of macrophages. MCs
were infected for ,16 hrs with GFP transfectants preloaded with
Pcs (10 mM) and light-exposed. Untreated Leishmania and uninfected MCs were included as controls. Normal donkey serum was
used to block non-specific interactions and rat anti-mouse CD16/
32 antisera (eBiosciences) for Fc receptors. Cells were fixed/
permeabilized with Cytofix-cytoperm (BD biosciences) for reaction
with goat anti-EEA1 antisera (sc-6414, Santa Cruz Biotech) [37]
and donkey anti-goat IgG-alexa594 (Molecular probes). [5]
Immunodetection of H-2Kb OVA(257–264) (SIINFEKL)
complexes of ova transfectant-infected DCs. DC2.4
dendritic cells (56104) were exposed for 24 hrs at 37uC, 5%
CO2, in 200 ul of complete medium to the following materials:
100 pM SIINFEKL, 5 mg/ml OVA, freeze thawed lysates of
Leishmania transfectants expressing OVA (56106 promastigotes),
csPc preloaded/light-exposed OVA transfectants or control
untransfected cells (56106 promastigotes) and medium alone.
Exposed cells permeabilized as earlier described were treated at
4uC for 16 hrs with the monoclonal from the 25-D1.16 hybridoma
culture supernatants followed by goat anti-mouse IgG-alexa488
(Molecular probes) (1: 1000 dilution) to assess the H-2Kb
OVA(257–264) (SIINFEKL) [31]. Fluorescence microscopy
filter sets (Chroma Technology Co., Brattleboro, VT) were
used for the fluorescence microscopy as follows: [1] D365/10X
(365 nm exciter), 400DCLP (400 nm dichroic) and D460/50M

Leishmania infection of host cells
MCs or DCs were mixed with Leishmania at a parasite-to-host
cell ratio of 10:1, i. e. 56106 Leishmania/56105 host cells/ml.
Infection was initiated by plating the mixtures under the following
conditions: [1] ,0.5 ml/well in 24 well tissue culture plates for
most studies; [2] 0.2 ml/well in 8 chamber microscopic slides for
immunofluorescence microscopy. Infected cultures were incubated
at 35uC, subjected to medium renewal, if necessary, and washed
before use.

In vitro photodynamic therapy
Late log-phase promastigotes/GFP transfectants and axenic
amastigotes were treated with Pcs each in 106 serial dilutions
(100 mM being the highest) at a cell density of 108 cells/ml in
Hank’s Balanced Salt Solution plus 0.01% bovine serum albumin
(HBSS-BSA) at pH 7.4 and pH 5.4, respectively [7,30]. Promastigotes and axenic amastigotes so treated were incubated in the
dark at 25 and 33uC, respectively.
Leishmania-infected (for 2–3 days) and non-infected cells at ,106
cells/ml were treated similarly with Pcs, but in their specific
culture conditions. Negative controls included both Leishmania
stages and infected/non-infected host cells, which were treated
with the solvent of Pcs at the highest concentration used, i. e. 0.1%
DMSO. DMSO at this concentration was not cytotoxic [7].
All Pc-treated cells were exposed to light with or without
removing the Pcs from the incubation milieu, Leishmania cells were
referred to as ‘‘pre-loaded’’ in the former case, i. e. 36
centrifugations of cells in HBSS each at 4uC for 5 min at
3,500 g. Host cell monolayers were 36 washed with the buffer.
Leishmania were plated at 26107 cells/0.2 ml/well and host cells at
0.25–0.56106 cells/0.5 ml/well in 96-well and 24-well tissue
culture plates, respectively. Illumination referred to as ‘‘lightexposure’’ was optimized as follows. The plated cells were placed
at a distance of ,3 cm from the light source at the bottom for
illumination over a red filter (wavelengths .650 nm; part
PLoS ONE | www.plosone.org
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J774 MCs preloaded with 10 mM of different csPcs for 16 hrs. A–
B-2nd column and C–D 1st column, csPc fluorescence; A-3rd
column and C-2nd column, mitochondria labeled with mitotracker
green; B-3rd column and D-2nd column endocytic vesicles labeled
with FITC-dextran. Note: No significant co-localization of csPc
15 fluorescence with mitotracker, and csPc 3.5 with endocytic
marker (Merged and enlarged columns A–D). This is further
clearly shown by line scans for intensity along the ‘‘white line’’ in
enlarged column A–D. Scale bar = 10 mm.
(DOC)

(460 nm emitter) for DAPI; [II] HQ480/40 (480-nm exciter),
Q505LP (505-nm dichroic), and HQ535/50 (535-nm emitter) for
green fluorescent protein (GFP), dextran-fluorescein isothiocyanate (dextran-FITC), rhodamine 123, mitotracker green and alexa
488; [III] HQ545/30 (545-nm exciter), Q570LP (570-nm
dichroic), and HQ620/60 (620-nm emitter) for alexa 594; and
[IV] HQ620/60 (620-nm exciter), Q660LP (660-nm dichroic),
and HQ700/80 (700-nm emitter) for phthalocyanines.

Antigen presentation assay
H-2Kb positive DCs or BDMCs were used to present OVA in
various forms (see details at the bottom of Figure 8C) to the B3Z T
cells [26], which express a TCR that specifically recognizes the
OVA(257–264) epitope (SIINFEKL) in the context of MHC I H2Kb. OVA-primed DCs or BDMCs and B3Z T cells were
incubated at 1:1 ratio for 24 hrs at 37uC in 96 or 24 well plates. b–
gal expressed by the lacZ reporter gene of B3Z T cells [26] in
response to MHC I+ SIINFEKL and TCR complex formation
were assessed by a b–gal-luciferase coupled assay system (BETAGLO Promega) as luminescence using Synergy HT plate reader
(BioTek). The assay was pre-calibrated for optimal response of the
T cells to the lowest concentrations of purified OVA (5 mg/ml)
(Millipore) and SIINFEKL (100 pM) (AnaSpec) [26,33]. In each
experiment, the values obtained from the experimental groups
were normalized against those from the positive controls as 100%.

Figure S2 Infection of DCs with csPc 3.5-loaded Leishmania and selective photolysis of the latter after
illumination of infected cells. [A–B, A9–B9] Phase contrast and fluorescence microscopic images of adherent
DC 2.4 cells showing clearance of GFP-Leishmania
infection: GFP transfected Leishmania (see green fluorescence)
were loaded overnight with or without 10 mM csPc 3.5 and used to
infect DC 2.4 cells. Infected monolayers were washed to remove
non-attached extracellular parasites and light-exposed. Cells were
examined by phase contrast and GFP fluorescence microscopy
immediately before [A–B] and 1 day after light exposure [A9–B9].
Note: The integrity of the DCs and the substantial clearance of
Leishmania green fluorescence from all cultures, except the control
infected with Leishmania without Pc pre-loading (untreated). Scale
bar = 100 mm. [C] GFP flow cytometry of infected cells,
showing substantial clearance of GFP Leishmania
infection: Similar culture sets as above were infected for 2 days
with csPc-preloaded (10 mM Pc 3.5) or control Leishmania, as
indicated. Cells were then light-exposed and detached with
trypsin-EDTA (Invitrogen) 1 day after light exposure. Cells were
assessed by flow-cytometry for GFP fluorescence as a measure of
infection. Note: The significant loss of GFP fluorescence due to
Leishmania photolysis in the DCs of the experimental group, but not
of the controls.
(DOC)

Flow cytometry
Infection of MCs and DC with GFP- or csPc-fluorescent
Leishmania was quantitatively assessed by flow cytometry [38] using
a Becton Dickenson flow cytometer (LSRII) equipped with BD
bioscience software FACS DIVA for data acquisition and analyses
[24].
All experiments were repeated 2–3 times. The data presented
represent the means 6 standard errors of the values in duplicate or
triplicate for each of the individual samples from representative
experiments. Statistical analysis was done using the student t-test.
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